Exposure-based Treatment for Avoidant Back Pain Patients
ETABP
Exposure Therapy in Chronic Low Back Pain Patients
1 other identifier
interventional
68
1 country
1
Brief Summary
Chronic low back pain often results in psychosocial and physical disability. A subgroup of these patients shows fear of (re)injury and avoidance behaviour leading to higher disability. The purpose of this study is to determine whether exposure in vivo is more effective in the treatment of fear avoidant chronic back pain patients than psychological treatment as usual (cognitive behavioural psychotherapy).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable low-back-pain
Started Aug 2011
Longer than P75 for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2011
CompletedFirst Submitted
Initial submission to the registry
November 28, 2011
CompletedFirst Posted
Study publicly available on registry
December 2, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2017
CompletedSeptember 5, 2017
September 1, 2017
4 years
November 28, 2011
September 1, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change from baseline in pain severity at 3 and 6 months after admission
Numeric Rating Scale (NRS)
from Pretest (admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)
Change from baseline in pain disability at 3 and 6 months after admission
Pain Disability Index (PDI) Quebec Back Pain Disability Scale (QBPDS)
from Pretest (admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)
Secondary Outcomes (5)
Change in fear avoidance from Pretest to two in-between time points to Posttest
from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)
Change in pain catastrophizing from Pretest to two in-between timepoints to Posttest to Follow-up
from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)
Change in emotional distress from Pretest to two in-between timepoints to Posttest to Follow-up
from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)
Change in quality of life from Pretest to two in-between timepoints to Posttest to Follow-up
from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)
Change in physical activity from Pretest to two in-between timepoints to Posttest to Follow-up Time
from Pretest (admission) to one in-between timepoint (an expected 10 weeks after admission) to Posttest (an expected average of 3 months after admission) to Follow-up (an expected average of 6 months after admission)
Study Arms (3)
A Exposure long
EXPERIMENTALExposure in vivo for fear avoidant chronic low back pain patients. This treatment means that the individual is exposed to movements and tasks that have been avoided due to fear of (re)injury. The treatment begins after three educational lessons including the rational and developing a fear hierarchy. Exposure phase includes 10 exposures sessions which are highly individualized. Behavioral experiments can be included to correct catastrophic misinterpretations. The main purpose of this intervention type is to reduce pain related disability via diminishing fear avoidance.
B Exposure short
EXPERIMENTALSee above exposure long. This treatment comprises 5 exposure sessions.
C Cognitive behavioural psychotherapy
ACTIVE COMPARATORCognitive behavioural psychotherapy for fear avoidant chronic low back patients. The therapy is modularized in three main parts. The educational lesson is followed by the module graded activity which represents the behavioral part of the program. The second module comprises relaxation. And the last part contains cognitive interventions. Cognitive behavioural intervention techniques are employed to support the patient in the process of coping with chronic pain: i.e. reduction of disability and improving functional ability.
Interventions
5-10 sessions based on an individualized fear hierarchy
graded activity, relaxation techniques and cognitive interventions
Eligibility Criteria
You may qualify if:
- Having at least 3 months back pain
- Sufficient level on fear avoidance scores (TSK, Phoda)
- Being German-speaking
- Agreeing to participate, verified by completion of informed consent
You may not qualify if:
- Red flags
- Pregnancy
- Illiteracy
- Psychoses
- Alcohol addiction
- surgeries during the last 6 months or planed surgeries
- Specific medical disorders or cardiovascular diseases preventing participation in physical exercise
- Participating in another psychotherapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Philipps University Marburglead
- Psychotherapie-Ambulanz Marburg e.V.collaborator
- German Research Foundationcollaborator
Study Sites (1)
Philipps University Marburg, Department of Clinical Psychology and Psychotherapy
Marburg, 35037, Germany
Related Publications (2)
Glombiewski JA, Holzapfel S, Riecke J, Vlaeyen JWS, de Jong J, Lemmer G, Rief W. Exposure and CBT for chronic back pain: An RCT on differential efficacy and optimal length of treatment. J Consult Clin Psychol. 2018 Jun;86(6):533-545. doi: 10.1037/ccp0000298.
PMID: 29781651DERIVEDRiecke J, Holzapfel S, Rief W, Glombiewski JA. Evaluation and implementation of graded in vivo exposure for chronic low back pain in a German outpatient setting: a study protocol of a randomized controlled trial. Trials. 2013 Jul 9;14:203. doi: 10.1186/1745-6215-14-203.
PMID: 23837551DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Winfried Rief, Prof.
Philipps University Marburg, Department of Clinical Psychology and Psychotherapy
- STUDY CHAIR
Julia A. Glombiewski, Dr.
Philipps University Marburg, Department of Clinical Psychology and Psychotherapy
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D, Licensed Psychologist, Principal Investigator
Study Record Dates
First Submitted
November 28, 2011
First Posted
December 2, 2011
Study Start
August 1, 2011
Primary Completion
August 1, 2015
Study Completion
August 1, 2017
Last Updated
September 5, 2017
Record last verified: 2017-09